RPG Life Sciences Limited (RPGLIFE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 30.72B |
| Enterprise Value | 29.42B |
| P/E Ratio | 38.67 |
| PEG Ratio | -0.8 |
| Price/Sales Ratio | 5.62 |
| Price/Book Ratio | 5.89 |
| Enterprise/Revenue | 5.51 |
| Enterprise/EBITDA | 24.26 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.14 |
| Operating Margin | 0.17 |
| Return On Assets | 0.1 |
| Return On Equity | 0.18 |
| Revenue | 7.08B |
| Revenue/Share | 490.44 |
| Gross Profit | 2.92B |
| EBITDA | 1.77B |
| Net Income | 1.15B |
| Diluted EPS | 69.64 |
| Total Cash | 2.93B |
| Total Cash/Share | 188.3 |
| Total Debt | 264.4M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 2.92 |
| Book Value Per Share | 556.03 |
| 52-Week Change | 10.7 |
| 52-Week High | 3,127.8 |
| 52-Week Low | 1,733 |
| Moving Average 50 Days | 2,774.61 |
| Moving Average 200 Days | 2,385.13 |
| Average Volume | 27,041 |
| Shares Outstanding | 16.54M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 24 |
| Trailing Annual Dividend Yield | 0.92 |
| Payout Ratio | 0.36 |
| Last Split Factor | N/A |
| Last Split Date | N/A |